n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Wednesday, November 15th, 2017

The QualityStocks
Daily Stock List

graphic
graphic

Kraken Robotics, Inc. (KRKNF)

OTC Markets, Morningstar, 4-Traders, Barchart, Stockhouse, InvestorsHangout, and TradingView reported on Kraken Robotics, Inc. (KRKNF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A marine technology company, Kraken Robotics, Inc.’s commitment is to the production and sale of software, sensors, and robotic systems for the worldwide Unmanned Maritime Vehicles market. The Company’s wholly-owned subsidiary is Kraken Robotic Systems, Inc. On September 20, 2017, Kraken Sonar, Inc. announced that it changed its name from Kraken Sonar, Inc. to Kraken Robotics, Inc. Effective Friday, September 22, 2017; it commenced trading under its new name. Kraken Robotics has its corporate headquarters in St. John’s, NL (Newfoundland and Labrador).

The Company’s series of SAS (Synthetic Aperture Sonar) products named AquaPix® takes advantage of almost 20 years of research and development (R&D) conducted by NATO’s Undersea Research Centre and millions of dollars in funding support from NATO government sponsors. AquaPix® provides comparable performance to existing high end military systems at a lesser cost.

AquaPix® can provide detailed seabed images with a constant resolution better than 3cm x 3cm out to a range of 300m from each side of an underwater vehicle (600m swath). Furthermore, it can produce 3D bathymetric data with a resolution better than 25cm x 25cm out to full range. This is while delivering very high depth accuracy, in compliance with IHO S44 special order requirements.

Moreover, Kraken has expanded from sensors to complete systems. It has introduced its KATFISH™ tethered underwater vehicle. In addition, it has introduced the THUNDERFISH® autonomous underwater vehicle (AUV).

Kraken also has its AQUATRAK® CVL product. This speed sensor is a derivative of the Company’s SAS technology. This product is for the oil and gas sector for ROVs.

Additionally, the Company has its Kraken SeaVision™ system. This is a pioneering new take on subsea 3D laser imaging. The design of it is to operate in a twin scanning configuration, with adjustable baseline. SeaVision can produce very high resolution 3D scans in full color.

Kraken Robotics also has its DataPod™ product. The design of it is to meet contemporary data storage requirements for rugged marine applications. DataPod™ combines the user-friendliness of a Network Attached Storage system with the reliability of a RAID array and solid state storage all in one compact unit.

In September 2017, Kraken Robotics announced that subsidiary Kraken Robotic Systems, Inc. was awarded a contract valued at more than $2,000,000. The contract involves the delivery of advanced sensors, underwater robotics, as well as software. Delivery of the entire contract is expected in Q4 2017.

Recently, Kraken Robotics announced that Kraken Robotic Systems entered a strategic partnership with Avitas Systems, a GE Venture. The companies will integrate Autonomous Underwater Vehicles (AUVs), acoustic and laser sensor technology and artificial intelligence-based navigation software into innovative subsea inspection solutions for the oil and gas, offshore renewable energy, and shipping industries.

Avitas Systems provides autonomous inspection with robots, which can target specific points on industrial assets and follow precise paths from digitized 3D models. Avitas Systems is advancing the inspection services industry across oil and gas, transportation, and electric power sectors via predictive data analytics, robotics, and artificial intelligence (AI).

Kraken Robotics, Inc. (KRKNF), closed Wednesday's trading session at $0.1305, up 8.93%, on 13,933 volume with 7 trades. The average volume for the last 60 days is 56,958 and the stock's 52-week low/high is $0.088/$0.20.

Elite Pharmaceuticals, Inc. (ELTP)

PennyStocks24, TopPennyStockMovers, Marketbeat.com, Promotion Stock Secrets, Pennybuster, SmallCapVoice, Top Stock Picks, and Stock Analyzer reported on Elite Pharmaceuticals, Inc. (ELTP), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Elite Pharmaceuticals, Inc. develops oral sustained and controlled release products. A specialty pharmaceutical company, it is developing a pipeline of proprietary pharmacological abuse-deterrent opioid products and niche generic products. The Company specializes in oral sustained and controlled release drug products, which have high barriers to entry. Elite Pharmaceuticals is based in Northvale, New Jersey, where it operates a GMP and DEA registered facility for research, development, and manufacturing.

The Company’s lead pipeline products include abuse-deterrent opioids that utilize its patented proprietary technology and a once-daily opioid. These products include sustained release oral formulations of opioids for the treatment of chronic pain.

Regarding Elite’s proprietary abuse-deterrent technology, ART™, it is a multi-particulate capsule that contains an opioid agonist in addition to naltrexone, an opioid antagonist used chiefly in the management of alcohol dependence and opioid dependence. When the product is taken as intended, the design of naltrexone is to pass through the body unreleased while the opioid agonist releases over time providing therapeutic pain relief for which it is prescribed.

In addition, Elite Pharmaceuticals provides contract manufacturing for Ascend Laboratories (a subsidiary of Alkem Laboratories Ltd.). Elite owns generic and Over-the-Counter (OTC) products that have been licensed to TAGI Pharma, Epic Pharma, Dr. Reddy’s Laboratories, and Valeant Pharmaceuticals International.

Currently, Elite Pharmaceuticals has nine commercial products selling, four products under review pending approval by the Food and Drug Administration (FDA), additional approved products pending manufacturing site transfer, and the NDA filing for SequestOx™.

Elite Pharmaceuticals announced earlier in 2017 that it started pharmacokinetic testing of its reformulated SequestOx™.  The expectation is that the reformulated product will have a shorter Tmax under fed conditions.

Elite is conducting a bioequivalence study that is a pivotal, open-label, randomized, single-dose, three-way, crossover study to evaluate the relative comparative bioavailability and bioequivalence of the modified formulation of SequestOx™ to the original formulation of SequestOx™ and to a comparator product under fed conditions. The study has enrolled 45 healthy volunteers - the first subjects have been dosed.

Elite Pharmaceuticals has filed an Abbreviated New Drug Application (ANDA) with the FDA for a generic version of OxyContin® (extended release Oxycodone Hydrochloride). OxyContin® is approved for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are insufficient. OxyContin® is formulated such that the tablets provide physical abuse deterrent properties.

In Q2 Fiscal Year 2018, ended September 30, 2017, Elite Pharmaceuticals continued the development of SequestOX™ and generic products being co-developed with SunGen Pharma. The product line undergoing development pursuant to the 2016 license and development agreement with SunGen, also grew, with the addition of four new generic products and the signing of an agreement to develop an additional five products using an innovative drug delivery platform used for extended release products.

Elite Pharmaceuticals, Inc. (ELTP), closed Wednesday's trading session at $0.0773, down 3.38%, on 467,053 volume with 27 trades. The average volume for the last 60 days is 754,281 and the stock's 52-week low/high is $0.056/$0.2495.

Envision Solar International, Inc. (EVSI)

Greenbackers, RedChip, FeedBlitz, Hotstocked, Stock News Now, SmallCapVoice, SmarTrend Newsletters, OTCJournal, and Stockwire reported earlier on Envision Solar International, Inc. (EVSI), and we report on the Company today, here at the QualityStocks Daily Newsletter.

Envision Solar International, Inc. is a renewable energy, media and branding, and EV charging product company. It is a developer of solar products and proprietary technology solutions. Envision Solar designs, manufactures, and deploys innovative, renewably energized, EV charging and media and branding systems. Envision Solar International lists on the OTC Markets Group’s OTCQB. The Company has its corporate office in San Diego, California.

Envision Solar International’s products include the patented EV ARC™ and Solar Tree® product lines. All of Envision Solar’s products can be enhanced with EnvisionTrak™ patented solar tracking, ARC Technology™ energy storage, SunCharge™ Electric Vehicle Charging Stations, and digital advertising packages.

The Company has designed and incorporated EnvisionTrak, its proprietary and patented tracking solution, to the Solar Tree structure. It has deployed its latest generation of Solar Tree products, the Solar Tree HVLC (High Value, Low Cost) array.

The new Solar Tree product incorporates its latest engineering and fabrication improvements. The Company’s Solar Tree® structure works as a billboard for a company’s green credentials. This is while producing clean energy and improving the aesthetics of any parking lot.

Envision Solar has also developed the aforementioned EV ARC™. It has observed that the EV ARC™ (Electric Vehicle Autonomous Renewable Charger) can solve manifold problems associated with electric vehicle charging infrastructure deployments. The EV ARC™ fits inside a parking space. It produces enough clean, solar electricity to power up to 225 miles of EV driving in a day.

In early November, Envision Solar International announced that UC Santa Cruz is deploying its EV ARC™ solar charging station product to provide EV charging for campus fleet vehicles. The deployment of EV ARC™ products takes place in minutes. In addition, the units are available to charge EVs right away.

The EV ARC™ product requires no trenching, foundations or installation work of any kind. It undergoes deployment in minutes. Furthermore, it can be moved to a new location easily.

Last week, OUTFRONT Media, Inc. (OUT) announced its agreement with Envision Solar International. OUTFRONT will market and sell the naming rights for Envision Solar's network of solar powered electric vehicle EV ARC™ charging stations across San Diego, California.

OUTFRONT Media connects brands with consumers outside of their homes via one of the largest and most diverse location-based asset portfolios in North America. OUTFRONT Media has its ON Smart Media platform.

Envision Solar International, Inc. (EVSI), closed Wednesday's trading session at $0.173, down 6.44%, on 145,531 volume with 25 trades. The average volume for the last 60 days is 99,674 and the stock's 52-week low/high is $0.09/$0.20.

Silver Bull Resources, Inc. (SVBL)

Wall Street Resources, Stockhouse, RedChip, Streetwise Reports, StreetInsider, TopPennyStockMovers, and Stock Stars reported previously on Silver Bull Resources, Inc. (SVBL), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Silver Bull Resources, Inc. is a mineral exploration enterprise headquartered in Vancouver, British Columbia. The Company’s flagship project is called "Sierra Mojada". This Project is positioned 150 kilometers north of the city of Torreon in Coahuila, Mexico. The Project is highly prospective for silver and zinc. An exploration stage company, Silver Bull Resources lists on the OTC Markets Group’s OTCQB.

Silver Bull’s Sierra Mojada Project is 100 percent owned and operated by the Company. The Sierra Mojada Project is part of a large land package comprising 40 mining concessions totaling 21,167 hectares (52,305 acres), situated in an historical high-grade silver, lead, zinc mining district discovered in 1879.

Sierra Mojada has high-quality infrastructure. This infrastructure includes a railway to the site; a paved road; grid power, and five company-owned water wells. Sierra Mojada is an open pittable oxide deposit.

The Sierra Mojada Project has an NI (National Instrument) 43-101 compliant measured and indicated Global resource of 58.7 million tonnes grading at 3.6 percent zinc and 50 g/t silver for 4.670 billion pounds of zinc and 90.8 million ounces of silver.

The primary mineralization zone found at Sierra Mojada extends greater than six kilometers in an East-West direction along the base of the Sierra Mojada Range parallel with the Sierra Mojada fault. More than 54 historical mine shafts lie along this strike, mining to depths in excess of 200 meters. This area has not been mined with modern mining technology and processes.

In September 2016, Silver Bull Resources announced that it commenced an exploration program to target potential sulphide mineralization at depth believed to be underneath and next to, the primary zone of mineralization already defined at Sierra Mojada. During August and September of 2016, it completed a 590-line kilometer airborne magnetic geophysics survey over the main deposit at Sierra Mojada targeting structures at depth.

More than 20,000 meters of drill core was re-logged over areas of high interest and a new structural model was developed for the primary deposit. In November 2016, Silver Bull announced that it started an initial 3,000-meter exploration drill program utilizing Major Drilling at the Sierra Mojada project in Coahuila.

Last month, Silver Bull Resources provided the results of the first two drill holes from its underground drill program targeting high grade structures in the newly discovered Sulphide Zone on the Sierra Mojada Project in Coahuila, Northern Mexico.

Highlights from the first two drill holes include Hole T17002 – 25.5 meters @ 294g/t silver and 0.96 percent copper including 11.5 meters @ 486g/t silver and 1.13 percent copper from 14 meters to 25.5 meters, and which contains a smaller interval of 4 meters @ 966g/t silver and 2.0 percent copper from 15 meters to 19 meters.

Furthermore, Hole T17002 hit underground workings. It was terminated in high grade mineralization. In addition, highlights include Hole T17001 – 7 meters @ 121g/t silver and 0.52 percent copper including 2 meters @ 376g/t silver and 3.0 percent copper from 0 meters to 2 meters.

Silver Bull Resources, Inc. (SVBL), closed Wednesday's trading session at $0.10312, up 2.10%, on 731,196 volume with 54 trades. The average volume for the last 60 days is 276,569 and the stock's 52-week low/high is $0.0605/$0.16.

Voip-Pal.com, Inc. (VPLM)

SmallCapAllStars, FeedBlitz, TheSUBWAY, Stock Twiter, Google Alerts, Pumps and Dumps, Equities, Clutch Investments, equities Canada, TryBestPennyStocks.biz, UndiscoveredEquities, SmallCapVoice, VC Stock Marketing, and Buzz Stocks reported previously on Voip-Pal.com, Inc. (VPLM), and we today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Voip-Pal.com, Inc. owns a portfolio of patents relating to Voice-over-Internet Protocol (VoIP) technology. The Company is now looking to monetize its fundamental patents through a sale or licensure of its technology. In December 1997, Voip-Pal.com incorporated in the State of Nevada. In 2013, it acquired Digifonica International (DIL) Limited to fund, co-develop, as well as complete Digifonica's patent collection.

Voip-Pal.com is based in Bellevue, Washington. The Company’s shares trade on the OTC Markets’ OTCQB.

Voip-Pal.com’s Intellectual Property (IP) value comes from many issued US Patent and Trademark Office (USPTO) patents. This includes five parent patents, one of which is foundational and the others which build upon the former. The five core patents are: Routing, Billing & Rating (RBR); Lawful Intercept; Enhanced E-911; Mobile Gateway; and Uninterrupted Transmission.

Voip-Pal.com earlier announced receipt of the Notice of Allowance from the USPTO for the Company’s “Intercepting Voice Over IP Communications and Other Data Communications,” Application No. 14/802,929. This is Voip-Pal.com’s third Lawful Intercept (LI) patent.

Voip-Pal.com believes that its Lawful Intercept patents could prove to be a vital tool for law enforcement in its efforts to fight crime and stop terror attacks. The technology provides the means for judicially authorized covert intercept of any kind of communications sent by way of VoIP. This includes voice calls, media, and messaging.

The Company’s patented technology provides Universal numbering ubiquity; network value as defined by Metcalfe; the imperative of interconnect, termination, and recompense for delivery of calls by other networks; and regulatory compliance in regulated markets. Additionally, its patented technology provides interconnection of VoIP networks to mobile and fixed networks; and maintenance of uninterrupted VoIP calls across fixed, mobile, and WiFi networks.

Last month, Voip-Pal.com announced receipt of a Notice of Allowance from the US Patent and Trademark Office (USPTO) for the its “Allocating Charges for Communications Services,” patent, application No. 14/325,181. This is the Company’s sixth continuation for its “Producing Routing Messages for Voice Over IP Communications.” (RBR) patent and its 17th U.S. patent overall.

Mr. Emil Malak, Voip-Pal.com Chief Executive Officer, stated, “We are very pleased to add this important patent to our already valuable intellectual property portfolio. This patent allows the metering of time usage for internet telephony which is now becoming the dominant form of telephone and messaging communications. Our patent process began in 2006 and has so far yielded us a total of 17 patents in the United States.”

Voip-Pal.com, Inc. (VPLM), closed Wednesday's trading session at $0.0205, up 2.50%, on 401,128 volume with 20 trades. The average volume for the last 60 days is 339,437 and the stock's 52-week low/high is $0.0125/$0.10.

FISION Corp. (FSSN)

TradingView, MarketWatch, and Bloomberg reported on FISION Corp. (FSSN), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

FISION Corp. is a cloud-based digital asset management and marketing automation company listed on the OTC Markets’ OTCQB. The Company serves enterprise clients in the health care, hospitality, financial/insurance, software, and technology industries. FISION has greater than 65,000 users in 21 countries. FISION is an effective sales enablement and marketing asset management tool. Established in 2011, FISION has its head office in Minneapolis, Minnesota.

FISION maximizes the brand potential of every sales interaction. The Company’s advanced, proprietary technology specializes in managing customers’ brand and marketing content. This enables marketing and sales people to rapidly and easily create compelling, personalized, on-brand communications that boost revenue and profits.

FISION’s solutions include simplified brand distribution, sales enablement, distributed & localized marketing, digital asset management, channel support, and measurement & analytics. The Company equips marketing and sales teams with a wide-ranging set of enablement capabilities built to solve distributed marketing challenges.

Regarding digital asset management, FISION’s centralized, cloud-based library supports nearly 200 different file kinds. It gives a client complete control over how company assets are stored, retrieved, and used.

Several Fortune 500 companies from a range of industries have adopted FISION’s inventive SaaS (Software as a Service) solutions. These include an international financial services company, an operator of the world’s largest business network, and a leading worldwide manufacturer of people movers.

FISION has completed the acquisition of Volerro Corporation (Minneapolis, Minnesota-based) following the announcement of a definitive purchase agreement on April 25, 2017. Volerro is a leader in cloud-based content collaboration and agile marketing technology.

Volerro enhances the FISION platform with complementary cloud-based collaboration, agile marketing, as well as sales enablement software. Volerro’s SaaS platform simplifies how enterprise teams create, refine, and distribute content. Volerro’s ReVu.Me cloud app permits team members to work on the same document in real-time with integrated chat and voice conferencing.

FISION was earlier awarded a U.S. patent (US9639551 B2) covering its cloud-based marketing technology named, “Computerized Sharing of Digital Asset Localization Between Organizations.” The Company’s patented platform’s innovative multi-tiered and multi-tenant functionality allows outside agencies and other marketing partners to securely access a company’s content repository, and also create collateral materials, which stays true to approved branding and messaging.

FISION will present at the 10th annual LD Micro Main Event taking place on December 5-7, 2017 at the Luxe Sunset Bel Air Hotel in Bel Air, California. The Company’s Founder and Chief Executive Officer, Mr. Mike Brown is scheduled to present on Thursday, December 7 at 9:00 a.m. Pacific time. Mr. Brown will participate in one-on-one meetings with institutional analysts and investors December 5-7.

FISION Corp. (FSSN), closed Wednesday's trading session at $0.1749, up 2.88%, on 35,150 volume with 4 trades. The average volume for the last 60 days is 17,431 and the stock's 52-week low/high is $0.09/$0.86.

New Jersey Mining Company (NJMC)

SmallCapVoice, London Irvine Report, and The Street reported on New Jersey Mining Company (NJMC), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

New Jersey Mining Company has built, and is the majority-owner and operator, of a fully-permitted, upgraded, 360-ton per day flotation mill and cyanide leach plant. Moreover, the Company is 100-percent owner of the Golden Chest Mine project. This is an historic lode gold producer that has been expanded, modernized, and operated by a first-class lessee. New Jersey Mining provides custom milling services for small-scale mining operations.

New Jersey Mining is based in Coeur d'Alene, Idaho. Its Mill office is in Kellogg, Idaho. The Company’s shares trade on the OTC Markets Group’s OTCQB.

New Jersey Mining can offer, for larger companies, a variety of mining and exploration services, including custom milling. The Company is pursuing near-term production of its own, with a longer-term vision toward district-scale deposit potential. The Company is ramping up the flotation mill to handle incoming ore shipments from the nearby Golden Chest Mine.

The flotation mill recycles process water. It uses a paste tailings disposal process patented by Company founder Mr. Fred Brackebusch to lessen impact on the environment. The New Jersey Mill can perform test and toll milling on material from mines and prospects within a broad radius of active mining camps in Montana, Idaho, and Washington.

New Jersey Mining announced in 2016 that it completed its purchase of a 50-percent interest in Butte Highlands Joint Venture LLC, owner of the fully-permitted, high-grade, underground Butte Highlands Gold Project south of Butte, Montana. New Jersey Mining’s interest in Butte Highlands is “carried to production” by the joint venture (JV) partner, Montana State Gold Company, LLC (MSGC).

In addition, New Jersey Mining completed its acquisition of GF&H in 2016. This is a private company that holds 374 acres of patented mining claims near New Jersey Mining’s Golden Chest Mine Project. The GF&H land package includes claims just south of the mine property and on-strike with the Idaho Fault.

New Jersey Mining announced in June of this year that efforts to widen the open pit at its Golden Chest Mine project resulted in a considerable expansion. This includes a 14-fold increase in tonnage and a 12-fold increase in mineable ounces of gold.

At the beginning of November, New Jersey Mining announced that underground operations started at its 100-percent owned Golden Chest Mine near Murray, Idaho. The Company is now operating from two locations at the Golden Chest Project – the open pit mine it developed and operated this year and also the underground mine that was largely developed in 2015 and readied for production in 2017. All ore is being shipped for processing to New Jersey Mining’s nearby New Jersey Mill.

New Jersey Mining Company (NJMC), closed Wednesday's trading session at $0.13, down 7.14%, on 9,566 volume with 4 trades. The average volume for the last 60 days is 51,806 and the stock's 52-week low/high is $0.0908/$0.17.

United Cannabis Corp. (CNAB)

Actual Gains, Broad Street, TopPennyStockMovers, OTCBB Journal, StocksImpossible, Cannabis Financial Network News, PricelessPennyStocks, PennyStockRumors.net, Stockgoodies, Promotion Stock Secrets, Wealth Insider Alert, Wall Street Mover, Market Intelligence Center Alert, Marketbeat, StreetAuthority Daily, Money Map Press, MyBestStockAlerts, and Wall Street Wolves reported on United Cannabis Corp. (CNAB), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

United Cannabis Corp.’s dedication is to the development of phyto-therapeutic based products supported by patented technologies for the pharmaceutical, medical, and industrial markets. The Company formed to provide leadership in the medical cannabis industry. This is through providing patient driven solutions intent on improving biomedical and pharmaceutical pursuits using cannabis-based research, products, and services. A biotechnology enterprise, the Company is the creator of Prana Bio Nutrient Medicinals. United Cannabis is based in Denver, Colorado.

United Cannabis provides consulting services, proprietary products, and licenses its intellectual property (IP) to businesses in the cannabis industry. The Company owns distinct IP relating to the legalized growth, production, manufacture, marketing, management, use and distribution of medical and recreational marijuana and marijuana infused products. It has established affiliate relationships with Harborside Health Center of California, Prana Bio Nutrient Medicinals, Bubbleman, Blue River, and Cannabinoid Research & Development (CRD).

The United States Patent and Trademark Office (USPTO) has issued US Patent #9730911, granting exclusive rights to United Cannabis’ proprietary formulations based on compounds extracted from cannabis plant materials. More precisely, it is the composition of matter regarding the use of phytocannabinoids, cannabinoids, and specific terpene profiles in liquid form. This composition of matter patent provides protection for the Company’s proprietary formulations.

United Cannabis’ A.C.T. Now Program and Prana Bio Nutrient Medicinals provide a comprehensive solution designed to allow physicians and patients to implement and monitor effective therapy protocols. Prana Bio Nutrient Medicinals is a total, full spectrum cannabinoid system. It uses the whole cannabis plant through controlling specific cannabinoid ratios, accurate dosing, and numerous non-abrasive delivery methods.

The A.C.T. Now program provides affordable patient driven programs with limitless combinations of cannabinoid-based products. Moreover, it provides nutritional recommendations to help patients suffering from chronic pain, opiate dependency, inflammation, glaucoma, PTSD, neuropathy, multiple sclerosis, fibromyalgia, Crohn’s, IBS, seizures, epilepsy, paralysis, autoimmune, autism, tumors, HIV/AIDS, and many kinds of cancer.

Prana Bio Nutrient Medicinal products provide patients a way to mix/match cannabinoids for therapeutic purposes. These products are licensed to regulated marijuana dispensaries. The Company employs an infusion process using select fatty acids, lipids, and specific combinations of cannabis derived terpenes to increase bioavailability.

In July 2017, United Cannabis announced the acquisition of a majority share of Prana Therapeutics, Inc. (PTI). Prana is a clinical stage biotechnology company developing Polymolecular Botanical therapeutics for the oncology, neurology, and orthopedic markets. Prana concentrates on developing targeted therapeutics for the prevention of the negative side effects of chemotherapy, management of rheumatoid arthritis, and treatment of brain cancer.

This month, United Cannabis announced that Jamaica's Ministry of Health registered the Company’s Prana CBD-Infused Water as a medicinal cannabis product. The Prana Water will be manufactured and distributed by United Cannabis’ Jamaican subsidiary, Cannabinoid Research & Development Limited (CRD).

CRD has commenced preliminary work to initiate production of other United Cannabis products in Jamaica. This includes its Prana P5 Hemp Bio Nutrient Capsules, Aromatherapy Roll-On, as well as Sublingual Drops.

United Cannabis Corp. (CNAB), closed Wednesday's trading session at $0.6395, up 10.26%, on 347,606 volume with 216 trades. The average volume for the last 60 days is 108,258 and the stock's 52-week low/high is $0.535/$2.50.

graphic

The QualityStocks
Company Corner

graphic
graphic

First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF)

The QualityStocks Daily Newsletter would like to spotlight First Cobalt Corp. (FTSSF). Today, First Cobalt Corp. closed trading at $0.552, up 2.22%, on 347,606 volume with 216 trades. The stock’s average daily volume over the past 60 days is 108,258, and its 52-week low/high is $0.535/$2.50.

First Cobalt Corp. (FTSSF) is pleased to announce an extensive sampling program at historic mining operations in the Cobalt Camp in Ontario. The program is intended to provide new insights into the distribution of cobalt, silver, nickel and copper from underground waste material brought to surface at these historic mining operations. Also today, NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company that delivers a new generation of social communication solutions for business, announced the online availability of its interview with First Cobalt Corp. president and CEO Trent Mell, who delves into the encouraging first test results from four of the company's 50 mines located in an historically mineral rich section of Ontario, Canada. The interview can be heard at http://nnw.fm/ftssf-interview-nov-2017

First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF), with headquarters in Canada, seeks to create the world's largest pure-play cobalt exploration and development company. The company's current focus is on its Greater Cobalt Project located in Silver Centre, Ontario. The company is also in the midst of a three-way merger with Cobalt One Ltd. and CobalTech Mining Inc. and on completion First Cobalt will control over 10,000 hectares of prospective land and 50 historic mining operations in the Cobalt Camp in Ontario, Canada, as well as a mill and a permitted refinery facility.

The merger agreements with Cobalt One Ltd. and CobalTech Mining Inc., announced earlier this year, will result in a combined land position of more than 10,000 hectares (nearly 25,000 acres) in the Cobalt Camp containing approximately 50 past cobalt/silver producers and working mines. Initial test results from a mineralogical assessment of sample material taken from various historical mines located throughout the Cobalt Camp show both cobalt-rich and silver-rich mineralization styles. Samples taken at the former Bellellen mine, located within the Greater Cobalt Project in Ontario, show high grade cobalt assays, prompting First Cobalt to increase its drilling program at that site.

First Cobalt Corp. is moving quickly to leverage its potential against an economic background that estimates global consumption for refined cobalt is set to grow at an average rate of approximately 5 percent per annum for the next 10 years. The electric vehicle market, in particular, is driving this sector since more than 50 percent of the world's current production of cobalt is used in the manufacture of rechargeable lithium-ion batteries. The global lithium-ion battery market, as estimated by Zion Market Research, indicates the value at around USD $31 billion in 2016 and is expected to generate revenue of nearly USD $68 billion by end of 2022, growing at a compound annual growth rate of slightly above 17 percent.

The company's clear pathway to production and cash flow generation includes being one of only four fully permitted cobalt extraction refineries in Canada with significant material and processing infrastructure on site. With the price of cobalt increasing significantly and its importance in the growing battery market underpinning a strong long-term demand forecast, First Cobalt Corp. and its mining interests are primed for success.

First Cobalt Corp. President and CEO Trent Mell, a mining executive and capital markets professional with extensive international transactional experience, is joined by a team of reputable and seasoned deal-makers, mine builders and mine operators with decades of global experience in exploration, business development, geoscience, engineering and finance. Disclaimer

First Cobalt Corp. Company Blog

First Cobalt Corp. News:

First Cobalt Begins Assessment of Economic Potential of Historic Muckpile Material

NetworkNewsWire Releases Exclusive Audio Interview with First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF)

NetworkNewsWire Announces Publication Discussing Cobalt Companies Eyeing Mining Opportunities in North America

Global Payout, Inc. (GOHE)

The QualityStocks Daily Newsletter would like to spotlight Global Payout, Inc. (GOHE). Today, Global Payout, Inc. closed trading at $0.02, up 7.53%, on 1,673,054 volume with 97 trades. The stock’s average daily volume over the past 60 days is 3,188,880, and its 52-week low/high is $0.0077/$0.04.

Global Payout, Inc. (GOHE) is pleased to announce that its majority owned subsidiary MoneyTrac Technology, Inc. is currently in the process of exploring potential strategic partnership opportunities with a variety of entities that are focused on helping banking organizations become compliant with Cannabis regulatory frameworks in states where it is available for medical or recreational purposes.

Global Payout, Inc. (GOHE) provides comprehensive payment solutions that can be fully customized for virtually any domestic and international organization distributing money worldwide. The company is committed to enabling global access to technology for optimizing financial transactions and delivering a global financial eco-system with top-tier banking institutions and the highest level financial technology partnerships.

Today, more than ever before, commercial enterprises and government institutions need powerful financial technology solutions that have the flexibility to deliver innovative customer centric services and drive operational efficiency gains throughout the organization. The Global Reserve Platform is Global Payout's fully configurable "banking-in-a-box" web-based platform that can fulfill the front-to-back office processing requirements of domestic, foreign exchange and international payment service providers. This platform is designed to improve work flow, operational efficiencies, and global financial management for enterprises operating across the globe.

The Global Reserve Platform can manage practically any financial product, including core and traditional banking products, online banking, card management, mobile wallets, merchant payment processing, biometric payments and authentication management, bill payments and P2P payments, international remittances, government benefits management, loans management, FOREX, and SWIFT / ACH / SEPA payments. Powered by the Global Reserve Administrative module, the platform can be customized for enterprises across a multitude of business sectors.

Investment in financial technology (FINTECH) companies has grown dramatically in recent years with the role of today's banks shrinking and demand for improved financial solutions continuing to rise. As the industry has continued to expand rapidly, Global Payout's management team has directed its focus on identifying the most promising market sectors with FINTECH needs. The four core areas selected are logistics, small and medium enterprises (SME), banking and travel.

In 2015, Global Payout introduced MoneyTrac Technology Inc. as a majority owned subsidiary to more effectively focus on the development of financial technologies that specifically address many of the challenges that enterprises in a variety of alternative and "high-risk" market sectors are faced with in processing financial transactions. Powered by Virtu Network Solutions, the MoneyTrac Technology platform is one the most configurable and intuitive financial technology platforms available to alternative and "high-risk" enterprises and provides them with solutions that effectively manages everything from pin debit and virtual currency, to compliance and cash flow logistics.

With the global economy constantly becoming more diversified and connected, Global Payout is well positioned with the technology software solutions its team has developed to address many different needs worldwide. Management has committed itself to exploring and identifying every avenue possible for further establishing itself as a recognized leader in FINTECH solutions. Disclaimer

Global Payout, Inc. Company Blog

Global Payout, Inc. News:

Global Payout’s Subsidiary, MoneyTrac Technology Inc. Explores Partnerships with Compliance Firms in the Cannabis Banking Sector

Global Payout’s MoneyTrac Technology, Inc. Heads to MJ Business Conference in Las Vegas

Global Payout’s MoneyTrac Technology, Inc. and Strategic Partner Pegasus Fintech, Inc. Make Strides with Development of Cryptocurrency Token for Cannabis Industry and Move Closer to Launch of ICO

Singlepoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight Singlepoint, Inc. (SING). Today, Singlepoint, Inc. closed trading at $0.0656, up 8.09%, on 4,638,197 volume with 323 trades. The stock’s average daily volume over the past 60 days is 7,519,524, and its 52-week low/high is $0.01/$0.415.

SinglePoint, Inc. (OTC:SING) today announces the soft launch of a bitcoin exchange aimed at solving payment issues plaguing the cannabis industry. SinglePoint sees vast opportunity for technology to solve payment issues related to high-risk transactions, specifically in the cannabis market. There is yet to be a standout leader in the cannabis payments space, and SinglePoint is looking to solidify its position through the company’s relationships and history of mobile payment offerings. The new solution can be utilized by any business from convenience stores to dispensaries in the 29 legal states and District of Columbia. For more information, or to sign up for the exchange, visit app.singleseed.com

Singlepoint, Inc. (SING) has grown from a full-service mobile technology provider to a publicly-traded holding company. Through diversification into horizontal markets, SinglePoint is building its portfolio by acquiring an interest in undervalued subsidiaries, thereby providing a rich, diversified holding base.

SinglePoint's approach is to first research and identify acquisition opportunities in which it can take an active and influential role among existing leadership to provide enhanced strategy and direction. Target companies are undervalued, cash-flow positive, with high potential and verified assets. SinglePoint acquires and takes controlling interest of successful candidate companies.

SinglePoint recently signed a Letter of Intent to acquire an interest in Jacksam Corp., dba Convectium, a profitable California-based provider of equipment, branding, and packaging solutions for the cannabis industry. Convectium has developed the world's first cartridge and vape pen oil filling machine for wholesale distribution to dispensaries. The 710Shark and 710Seal systems can fill and package over 100 cartridges or disposable vape pens in 30 seconds and are sold to dispensaries through its EquipCanna.com brand. The company also operates a consumer brand that includes BlackoutX and HazeSticks and reaches customers in over 52 countries.

Additionally, SinglePoint has raised more than $300,000 and has signed a Letter of Intent to secure an additional $1 million in funding. The move provides management with ample capital to execute its business plan, while avoiding debt repayments that can eat into cash flow and reduce flexibility over time. It's also a rare development for a development-stage company in the cannabis industry.

Guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital, SinglePoint continues to explore high-potential acquisition opportunities to grow and diversify its current holding base. The company also plans to uplist to the OTCQB and become a fully reporting company during the current fiscal year.

The company has engaged Milost Advisors to pursue acquisitions and financing facilities toward funding acquisitions, as well as to provide working capital. Milost Advisors will assist SinglePoint in the acquisition of undervalued companies with annual revenues of at least $50 million, and has already identified potential acquisition targets for the company to consider. Disclaimer

Singlepoint, Inc. Company Blog

Singlepoint, Inc. News:

SinglePoint (SING) Launches Proprietary Bitcoin Exchange to Solve Payment Processing Issues in High-Risk Markets

CEO Greg Lambrecht Interviews on Strategy with Singlepoints Products

CannabisNewsWire Announces Publication Discussing Companies Creating New Forms of Revenue in the Growing Cryptocurrency Sector

Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF)

The QualityStocks Daily Newsletter would like to spotlight Petroteq Energy Inc. (FTSSF). Today, Petroteq Energy Inc. closed trading at $1.03, off by 4.63%, on 11,260 volume with 26 trades. The stock’s average daily volume over the past 60 days is 24,726, and its 52-week low/high is $0.015/$1.6717.

Petroteq Energy Inc. (TSX.V:PQE) (OTCQX:PQEFF), a company focused on the development and implementation of proprietary technologies for the environmentally safe extraction of heavy oils from oil sands, oil shale deposits and shallow oil deposits, announced today the reconstruction of a new large-scale oil extraction facility following its relocation to the TME mine site. The construction will expand the Company's operations and increase production capacity from 250 to 1,000 barrels per day.

Petroteq Energy Inc. (TSX.V: PQE) (OTCQB: PQEFF), with headquarters in Canada, seeks to create the world's largest pure-play cobalt exploration and development company. The company's current focus is on its Greater Cobalt Project located in Silver Centre, Ontario. The company is also in the midst of a three-way merger with Cobalt One Ltd. and CobalTech Mining Inc. and on completion First Cobalt will control over 10,000 hectares of prospective land and 50 historic mining operations in the Cobalt Camp in Ontario, Canada, as well as a mill and a permitted refinery facility.

The merger agreements with Cobalt One Ltd. and CobalTech Mining Inc., announced earlier this year, will result in a combined land position of more than 10,000 hectares (nearly 25,000 acres) in the Cobalt Camp containing approximately 50 past cobalt/silver producers and working mines. Initial test results from a mineralogical assessment of sample material taken from various historical mines located throughout the Cobalt Camp show both cobalt-rich and silver-rich mineralization styles. Samples taken at the former Bellellen mine, located within the Greater Cobalt Project in Ontario, show high grade cobalt assays, prompting First Cobalt to increase its drilling program at that site.

Petroteq Energy Inc. is moving quickly to leverage its potential against an economic background that estimates global consumption for refined cobalt is set to grow at an average rate of approximately 5 percent per annum for the next 10 years. The electric vehicle market, in particular, is driving this sector since more than 50 percent of the world's current production of cobalt is used in the manufacture of rechargeable lithium-ion batteries. The global lithium-ion battery market, as estimated by Zion Market Research, indicates the value at around USD $31 billion in 2016 and is expected to generate revenue of nearly USD $68 billion by end of 2022, growing at a compound annual growth rate of slightly above 17 percent.

The company's clear pathway to production and cash flow generation includes being one of only four fully permitted cobalt extraction refineries in Canada with significant material and processing infrastructure on site. With the price of cobalt increasing significantly and its importance in the growing battery market underpinning a strong long-term demand forecast, Petroteq Energy Inc. and its mining interests are primed for success.

Petroteq Energy Inc. President and CEO Trent Mell, a mining executive and capital markets professional with extensive international transactional experience, is joined by a team of reputable and seasoned deal-makers, mine builders and mine operators with decades of global experience in exploration, business development, geoscience, engineering and finance. Disclaimer

Petroteq Energy Inc. Company Blog

Petroteq Energy Inc. News:

Petroteq Energy, Inc. Discloses Progress on New Upscaled Oil Extraction Facility

Petroteq Energy, Inc. and First Bitcoin Capital Corp. Announce Blockchain-based Initiative to Optimize Oil & Gas Supply Chain Management

Petroteq Energy Inc. Secures Interest-Free Loan From Founder to Increase Facility and Accelerate Production Capacity

Grey Cloak Tech, Inc. (GRCK)

The QualityStocks Daily Newsletter would like to spotlight Grey Cloak Tech, Inc. (GRCK). Today, Grey Cloak Tech, Inc. closed trading at $0.0114, off by 2.56%, on 6,112,580 volume with 99 trades. The stock’s average daily volume over the past 60 days is 6,330,234 and its 52-week low/high is $0.0083/$0.35.

Grey Cloak Tech Inc. (OTCQB: GRCK) today announces its purchase of the domain CBD.co. This announcement is made just as the Marijuana Business Conference (MJ BizCon) in Las Vegas is underway. Grey Cloak's vision for CBD.co is to make it a media destination and the primary marketplace for all types of hemp products, with the main focus on cannabidiol (CBD) products. 

Grey Cloak Tech, Inc. (OTCQB: GRCK), a Las Vegas, Nevada-based company, aims to expand into the rapidly growing cannabinoid (CBD) market through the pending acquisition of Eqova Life Sciences, which focuses on providing a full spectrum line of clinical-grade hemp oil (CBD) products to the medical practitioner market. Eqova Life Sciences, based in Denver, Colorado, develops its own high quality, branded product line of hemp oil health products, with the offer of producing private labels to qualified partners.

Eqova Life Sciences recently exhibited the company's CBD products at the Integrative Medicine Summit in Denver, Colorado, which was attended by over 200 medical professionals. As part of the exhibition, Eqova Life Sciences also debuted its new CannaBio Salve, an innovative topical salve infused with several aromatic natural oils. The company's formulations combine the scientifically-validated, powerful benefits of cannabinoids in standardized products which are then distributed to patients under the care of qualified health practitioners. All Eqova products are carefully researched and go through rigorous third-party testing before and after marketing, providing the security of a clinical-grade product made in cGMP Compliant Labs located in the United States.

According to The Hemp Business Journal, the CBD products marketplace is projected to grow 700 percent by 2020 with annual sales reaching $2.1 billion. The purchase of Eqova Life Sciences would be a natural fit for the company, which has been looking for a way to build shareholder value by adding acquisitions from the rapidly growing CBD sector. Grey Cloak Tech believes medical practitioners seeking high-quality CBD products represent a vastly underserved market. To date, no other hemp oil company has exclusively focused on providing clinical-grade, full-spectrum hemp oil products to this important segment of the medical community.

Grey Cloak Tech also develops advanced software to overcome costly digital threats, most commonly known as online fraud. Grey Cloak Tech leads the industry with continuous development of the most comprehensive and effective weapons against online security threats. The company's proprietary digital advertising fraud detection software, Fraudlytic, provides a cloud-based, secure platform that monitors Internet traffic in real time, blocking malicious and false clicks, while allowing real consumers to view offers and make purchases. Disclaimer

Grey Cloak Tech, Inc. Blog

Grey Cloak Tech, Inc. News:

Grey Cloak Tech, Inc. Announces Purchase of CBD.co Domain and Plans to Build a CBD Marketplace

Grey Cloak Tech, Inc. to Introduce CannaBio Salve at MJBizCon in Las Vegas

Grey Cloak Tech Clarifies Reverse Split

ABcann Global (TSX.V:ABCN) (OTCQB:ABCCF)

The QualityStocks Daily Newsletter would like to spotlight ABcann Global (ABCCF). Today, ABcann Global closed trading at $0.8952, off by 1.63%, on 502,906 volume with 343 trades. The stock’s average daily volume over the past 60 days is 297,068 and its 52-week low/high is $0.6171/$1.25.

ABcann Global (TSX.V:ABCN) (OTCQB:ABCCF) today announced key additions to the Company’s leadership team, that are expected to accelerate the execution of its business plan and growth strategy. Also today, NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, announced the publication of an editorial featuring ABcann Global. The publication, titled, "Canadian Licensed Producers Prepare for Recreational Cannabis Legalization, Expect Significant Growth in Demand," highlights the anticipated surge in demand for cannabis products when recreational marijuana becomes legal in Canada mid-2018, and the responsibilities licensed growers have in the booming industry. To view the full publication, visit: https://www.networknewswire.com/canadian-licensed-producers-prepare-recreational-cannabis-legalization-expect-significant-growth-demand/

ABcann Global (TSX.V: ABCN) (OTCQB: ABCCF) ABcann Medicinals, Inc. is a globally licensed, cost efficient producer of premium quality organic standardized medicinal cannabis. One of the earliest licensed Canadian medical marijuana producers under Canada's federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), ABcann has five years of operating experience in the burgeoning medical marijuana space. The company currently owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario. Additionally, ABcann owns 65 acres of real estate with proper zoning and existing infrastructure in place to support the construction of another production facility of up to one million square feet.

In a November 2016 report, market research firm Canaccord Genuity Group forecasted that the medical marijuana market in Canada could see sales in excess of $8 billion by 2024, creating a sizable opportunity for the country's licensed producers (LPs). The research firm also noted that the "rigorous process of becoming a licensed producer of cannabis in Canada imposes significant barriers to entry and there will be a shortfall of supply in a legalized market in the short-term." This market barrier serves as a strategic advantage for ABcann as it prepares for its highly-anticipated IPO, which is currently scheduled for April 2017.

Canaccord's synopsis of the Canadian cannabis industry is supported by recent market activity, as companies sporting one of the illustrious Canadian government licenses for medicinal production have recorded strong growth following IPO. Canopy Growth (OTC: TWMJ), one of the largest fully-licensed Canadian marijuana growers, saw share prices skyrocket by more than 700 percent in the months following its initial offering. Aphria Inc. (OTC: APHQF), another licensed grower, climbed by more than 900 percent following its IPO. Other companies that have recorded huge growth since going public include Aurora Cannabis (OTC: ACBFF), climbing nearly 900 percent, and SupremePharma (OTC: SPRWF), which soared more than 1,300 percent.

With these market trends in mind, ABcann's impending IPO is one that prospective investors in the marijuana sector will want to explore. Recalls from some of the biggest players in the Canadian cannabis industry have highlighted the considerable learning curve that LPs face in today's market, which makes ABcann's proven track record in the market all the more noteworthy. The company has built a reputation over the years for its best-in-class standardized approach to growing cannabis, including the thoughtful omission of pesticides and a computer monitored growing technique that allows ABcann to minimize the risks of variance in its yields and ensure the creation of consistently high-quality products.

This technique, which the company calls the ABcann Advantage, has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with ABcann's current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry. This global growth potential is illustrated by ABcann's partnership with Israel's Syqe Medical, producer of the world's first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting the company's production facility, Perry Davidson, founder of Syqe Medical, noted that ABcann's production technologies put it "in a class with the best in the world" in its ability to produce standardized pharmaceutical grade cannabis.

ABcann's entry into the public sector is being guided by a seasoned management team, board of directors and advisory board that feature well over a century of combined industry experience. Ken Clement, the company' founder and executive chairman, has been the key component and driving force behind ABcann's development since its inception. His vision of standardized production and dosage sets ABcann apart in the medical cannabis sector. Clement is joined on the company's management team by CEO Aaron Keay. Keay brings more than a decade of capital markets experience to ABcann, having played a role in raising approximately $250 million for public and private market issuers.

Notably, ABcann also has access to the 'Father of Cannabis Research', Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC), and he has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.

With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, ABcann is well-positioned to compete in the rapidly-expanding Canadian medicinal cannabis industry. These factors, along with the company's ongoing global expansion into the European, Australian and Israeli markets, show why ABcann Medicinals' upcoming public offering fits the bill as "Canada's Next Medical Marijuana IPO." Disclaimer

ABcann Global Blog

ABcann Global News:

ABcann Global Strengthens Board and Executive Team

NetworkNewsWire Announces Publication on Anticipated Demand as Canada Prepares for Legalization of Recreational Marijuana

ABcann Global Appoints New Independent Chair

InMed Pharmaceuticals, Inc. (CSE:IN) (OTCQB:IMLFF)

The QualityStocks Daily Newsletter would like to spotlight InMed Pharmaceuticals, Inc. (IMLFF). Today, InMed Pharmaceuticals, Inc. closed trading at $0.54, off by 9.97%, on 1,559,190 volume with 809 trades. The stock’s average daily volume over the past 60 days is 685,255, and its 52-week low/high is $0.09/$0.72.

NetworkNewsWire. a multifaceted financial news and publishing company, today announces the publication of an editorial featuring InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF), a preclinical stage biopharmaceutical company specializing in the research and development of novel, cannabinoid-based prescription drug therapies utilizing novel drug delivery systems. The publication, titled, "Biosynthesis: Making the Impossible Possible in Medicinal Cannabis," reviews the roadblocks and hurdles cannabis researchers face under various regulatory jurisdictions and the innovative approaches now available for solving this widespread issue. To view the full publication, visit: https://www.networknewswire.com/biosynthesis-making-impossible-possible-medicinal-cannabis/

InMed Pharmaceuticals, Inc. (IMLFF) is a preclinical-stage biopharmaceutical company specializing in the development of novel therapeutics leveraging the pharmacological benefits of cannabinoids. Utilizing its proprietary bioinformatics assessment tool, InMed aims to identify bioactive compounds found within the cannabis plant that have the potential to offer optimized therapeutic benefit while demonstrating limited adverse effects. This assessment tool, in combination with the company’s cannabinoid biosynthesis technology and drug development pipeline, serves as InMed’s fundamental value driver.

Bioinformatics is a proprietary, computer-based program designed to assist in the identification of novel cannabinoids using comprehensive algorithms to integrate data from numerous bioinformatics databases, as well as a database on the structure of currently approved pharmaceutical products and an extensive database on over 90 individual cannabinoid drugs found in cannabis. This extensive collection of data is derived from both public and propriety-based sources. Leveraging this tool, the company aims to create associations between approved pharmaceuticals and cannabinoids with similar structures in order to identify active cannabinoids that have the potential to treat specific diseases. Per InMed’s website, this type of bioinformatics assessment represents “significant promise for future drug discovery, as it integrates many data sets and builds holistic models to approach a specific disease.”

After discovering these promising active cannabinoids, InMed moves to test and confirm their activity in biological systems through in vitro and in vivo experimentation. It is at this stage of development that the company’s proprietary biosynthesis process of cannabinoid manufacturing will be most promising. InMed is currently developing a robust, high-yield biosynthesis process for manufacturing all 90+ naturally-occurring cannabinoids. By modifying the agriculture-based formula for harvesting cannabinoids, InMed aims to combine the inherent safety and known efficacy of the natural drug structure with the convenience, control and quality of 21st Century laboratory-based manufacturing processes.

The company’s pipeline currently includes two drug candidates in preclinical development, including INM-750 for the treatment of epidermolysis bullosa (EB) and INM-085 for the treatment of glaucoma. Referred to by the Dystrophic Epidermolysis Bullosa Research Association of America as “The Worst Disease You’ve Never Heard Of,” EB is a rare genetic connective tissue disorder that affects roughly one out of every 20,000 births in the United States. The condition currently has no approved treatment or cure. Through the development of INM-750, InMed is attempting to address this significant unmet medical need. The drug candidate replaces missing keratins in the skin with specially selected cannabinoids in an effort to modulate the painful manifestations of EB.

INM-085, InMed’s second development candidate, is formulated to reduce the elevated intra-ocular pressure that is often associated with glaucoma. Additionally, the cannabinoids utilized in INM-085 are expected to provide neuroprotection for the retinal ganglion cells and other optic nerve tissues following topical administration. Although it is still in preclinical development, INM-085 targets a sizable market. According to the Glaucoma Research Foundation, glaucoma is a leading cause of blindness with no approved cure. The National Institutes of Health estimates that more than 3 million Americans currently have glaucoma, and more than 120,000 have been blinded by the disease.

InMed is focused on progressing toward validation of its drug candidate selection, using data to secure its patents and developing key disruptive technologies. In 2016, the company was successful in completing financings of $1.9 million. In January 2017, InMed completed a non-brokered private placement of common shares generating aggregate gross proceeds of C$1.5 million, strongly positioning the company to attract the new investment required to fund its aggressive growth strategies in 2017.

The company’s management team has well over a century of combined experience in the biopharmaceutical space. Company CEO Eric Adams has more than 25 years of experience in company and capital formation, global market development, mergers and acquisitions, licensing and corporate governance. During his time as CEO of enGene Inc., he led the gene therapy startup to a position at the head of the industry.

Joining Adams on the InMed management team are Chief Scientific Officer Dr. Sazzan Hossain; Senior Vice President, Clinical and Regulatory Affairs Alexandra D.J. Mancini; SVP, Corporate Strategy & Investor Relations Chris Bogart; and Chief Financial Officer Jeff Charpentier, as well as Chief Medical Officer Dr. Ado Muhammed, MD, DPM, MFPM.

Muhammed, in particular, has an extensive history in the pharmaceutical industry, having previously served as an executive of GW Pharmaceuticals, a global leader in the development of cannabinoid-based medicines. During his time as Associate Medical Director of that company, Muhammed played an instrumental role in the development and FDA approval of one of the first cannabis drugs. This GW Pharmaceuticals development program coincided with a sharp rise in share price from less than $9 in 2013 to more than $129 today, with the company’s current market value totaling more than $2.9 billion. Disclaimer

InMed Pharmaceuticals, Inc. Company Blog

InMed Pharmaceuticals, Inc. News:

NetworkNewsWire Announces Publication Featuring Innovative Approach to Cannabis R&D

NetworkNewsWire Announces Publication that Highlights Big Pharma's Increasing Interest in Cannabis Biotech Companies

NetworkNewsWire Announces Publication Highlighting Big Pharma's Appetite for M&A Possibilities in Cannabis

Algae Dynamics Corp. (ADYNF)

The QualityStocks Daily Newsletter would like to spotlight Algae Dynamics Corp. (ADYNF). Today, Algae Dynamics Corp. closed trading at $0.08, off by 20.00%, on 13,474 volume with 2 trades. The stock’s average daily volume over the past 60 days is 9,185 and its 52-week low/high is $0.0001/$0.62.

Algae Dynamics Corp (ADYNF) a developer of unique health products utilizing cannabis and algae oils, today announced that it has secured a US$250,000 investment from Teewinot Life Sciences Corporation (“Teewinot”). Teewinot is a leader in the development of biosynthetic cannabinoids that have the identical chemical structure of cannabinoids found in the Cannabis plant. The Company intends to use the funds for its research programs with The University of Waterloo and University of Western Ontario, that have been announced previously, as well as for general & administrative expenses and compliance.

Algae Dynamics Corp. (ADYNF) is focused on developing proprietary research and products involving botanical oils derived from cannabis and algae.

The original core of the company's product development strategy was the extraction of Omega-3 fatty acids from certain strains of algae with high concentrations of DHA to create various nutraceutical products. As a result of the many demonstrated health benefits of other botanical oils, most notably cannabis oil, Algae Dynamics developed a strategy aimed at developing products that combined the health benefits of algae and cannabis oils. Capitalizing on the burgeoning demand for cannabis oil and other smoke-free alternatives to marijuana consumption will help support ongoing initiatives to create and market research-driven product formulations.

Although the company is publicly traded in the U.S., business is conducted in Canada with no exposure to U.S. federal regulation involving cannabis. The Canadian cannabis oil extraction marketplace is projected to grow from C$1 million in 2015 to C$1.7 billion in 2020, which is more than a 1,000-fold increase. With the Government of Canada indicating a target date for full legalization on or before July 2018, numerous opportunities for sales in extracts and oils will open up very soon.

Using Colorado as a comparable example, a study performed by Mackie Research Capital found that 45% of dried marijuana users in the state would eventually convert to marijuana extracts and oils. This is because most consumers taking cannabis for medical purposes are increasingly looking for delivery systems that do not involve smoking marijuana. The market's attractiveness can be further realized when considering that the Canada's licensed producer marketplace is far less competitive with 45 current licensed producers for the whole country vs. 624 licensed cultivators in Colorado.

Collaborating with prominent Canadian universities is a core part of the Algae Dynamics' plan to bolster cannabis extraction expertise, develop premium products and add to its portfolio of intellectual property. Through its agreements with the University of Waterloo and the University of Western Ontario, the company is focusing primarily on the use of extracts from cannabis oil and algae oil in the context of cancer as well as the development of new pharmacotherapies for mental health.

Near-term goals include expanding research and development work with existing and new Canadian universities, securing supply/service agreements with licensed producers, and submitting an application to Health Canada to become a licensed producer of medical marijuana and ultimately have a license to sell products derived from cannabinoids. Algae Dynamics also owns a proprietary technology for the cultivation of low cost, highly pure algae biomass, which will be developed as a vertical integration strategy in the future to support the need to source algae oil for research-driven product formulations. The management team leading these initiatives has nearly a century of beneficial experience spanning from management and process experience to successful fund raising and commercialization.

As part of its key objective to be the #1 research Canadian cannabis oil research-driven product formulator, the company has also formed a strong team of scientific and strategic advisors that complement ongoing R&D relationships and initiatives. Individuals who support the company's initiatives include Dr. Jonathan Blay PhD, FRSB, FIBMS, Csci, CBiol, who performs research and product development on cannabis oil and its constituents in the context of colorectum, pancreas, breast and prostate cancers; and Dr. Steven Laviolette, BSc, PhD, who performs research and product development on cannabis oil and its constituents in the context of depression, post-traumatic stress disorder, anxiety and schizophrenia.

With such a strong foundation laid in the areas being pursued, Algae Dynamics is well positioned to execute on its carefully developed business plan to fast-track to revenue growth while having a longer-term strategy to build a sustainable enterprise-building opportunity in a rapidly expanding market. Disclaimer

Algae Dynamics Corp. Blog

Algae Dynamics Corp. News:

Algae Dynamics Corp Secures Us $250,000 Investment from Teewinot Life Sciences Corporation

Algae Dynamics Corp Enters Into a Letter of Intent with Bonify to Produce Unique Cannabis Oil Products; Accelerates Go-to-Market Strategy

NetworkNewsWire Releases Exclusive Audio Interview with Algae Dynamics Corp. (ADYNF)

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

MarketClub Analysis
(CHFS) +337.67%

2.

Daily Trade Alert
(YY) +24.83%

3.

PoliticsAndMyPortfolio
(ARSC) +24.22%

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251